₹1,150.00
+₹25.50 (+2.27%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹1,12,718 Cr
P/E
24.54
ROE
18.59%
ROCE
17.35%
About Zydus Lifesciences Ltd
Zydus Lifesciences operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.(Source : 202503-Annual Report Page No:291)
Founded
1995
CEO
Pankaj R Patel
Employees
36,827
HQ
Ahmedabad, India
About Zydus Lifesciences Ltd
Zydus Lifesciences operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.(Source : 202503-Annual Report Page No:291)
Founded:1995
CEO:Pankaj R Patel
Employees:36,827
HQ:Ahmedabad, India
Finished Products
1Sale of Products
₹51,995.30Cr2Other Operating Revenues
₹896.70Cr3Contract Manufacturings
₹376.00Cr4Export Incentives
₹350.60Cr5Others
₹262.80Cr6Netgain on Foreign CurrencyTr.
₹145.00Cr7Licence Fees
₹80.60Cr1–7 of 9
Raw Materials
1Raw Material Consumed
₹13,686.00Cr2Purchases of Finished Goods
₹1,284.90Cr3Packing Materials
₹965.70Cr4Purchases of Stock in Trade
₹197.70CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,205
52W Low
₹836
Volume1.40M
Avg VolumeN/A
Beta0.71
Dividend Yield0.09%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
24.54x
Valuation
P/B Ratio
4.16x
Valuation
EPS
₹46.04
Valuation
Dividend Yield
0.09%
Valuation
ROE
18.59%
Profitability
ROCE
17.35%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceuticals
+9.1%82.6%
₹22,412.1 Cr
Consumer Products
+46.6%14.6%
₹3,954 Cr
Medical technologies
+32495.8%2.9%
₹782.3 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
35.8%
International
64.2%
US43.2%
India35.8%
Others11.2%
Europe9.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
E
Ethical Holdings Plc
United Kingdom
0.00% stakeB
Beta Pharmaceuticals Corporation
Uruguay
0.00% stakeE
Ethical Pharmaceuticals South America SA
Argentina
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.46x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
37.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.